tiprankstipranks
Trending News
More News >
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276)
:1276
Hong Kong Market
Advertisement

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) Similar Stocks

Compare
3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
HK$72.30
HK$446.88B
61.47
5 Buy
2 Hold
1 Sell
Moderate Buy
CSPC Pharmaceutical Group
$0.95
$10.87B
20.37
44.09%
11 Buy
3 Hold
5 Sell
Moderate Buy
Wuxi Biologics (Cayman)
$4.50
$18.18B
31.45
102.25%
12 Buy
4 Hold
1 Sell
Moderate Buy
WuXi AppTec Co., Ltd. Class H
HK$102.20
HK$297.96B
17.92
94.22%
12 Buy
1 Hold
0 Sell
Strong Buy
Hansoh Pharmaceutical Group Company Limited
HK$36.04
HK$216.05B
41.10
109.17%
16 Buy
1 Hold
0 Sell
Strong Buy
BeiGene Ltd
HK$183.80
HK$275.52B
-178.05
46.03%
13 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1276
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
72.30
18.60
34.64%
CHJTF
CSPC Pharmaceutical Group
0.95
0.26
37.68%
WXIBF
Wuxi Biologics (Cayman)
4.50
2.26
100.89%
HK:2359
WuXi AppTec Co., Ltd. Class H
102.20
45.82
81.27%
HK:3692
Hansoh Pharmaceutical Group Company Limited
36.04
18.75
108.44%
HK:6160
BeiGene Ltd
185.60
63.80
52.38%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis